David Jay Klein, MD Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 10085 William F. Bernart Circle, Nassawadox, VA 23413 Phone: 757-414-8355 Fax: 757-414-8016 |
News Archive
In a study presented at the 35th Congress of the European Society for Medical Oncology (ESMO), Dr Giovanni Bernardo from Fondazione Maugeri in Pavia, Italy, presented results that suggested it may be possible to identify subsets of metastatic breast cancer patients who are likely to respond to subsequent lines of chemotherapy.
The Lewis Katz School of Medicine at Temple University and Hunter College of the City University of New York have jointly received a five-year, $13.5 million grant from the National Cancer Institute.
Oncothyreon Inc. today announced that Merck KGaA, Darmstadt, Germany, has initiated the international Phase 3 START2 study, which is designed to assess the efficacy and safety of the investigational MUC1 antigen-specific cancer immunotherapy tecemotide (also known as L-BLP25) in patients with unresectable, locally advanced Stage III non-small cell lung cancer (NSCLC).
A University of Guelph professor has uncovered the "secret" to staying strong as we age - superb fitness.
A groundbreaking free tool to help oncologists choose the best therapies for patients with non-small-cell lung cancer has been launched this week by scientists at the 1st European Lung Cancer Conference jointly organized by the European Society for Medical Oncology (ESMO) and the International Association for the Study of Lung Cancer (IASLC) in Geneva, Switzerland.
› Verified 3 days ago